Ares Capital Europe Ltd Form 8 (OPD) Offeror (2780Y)
20 Fevereiro 2013 - 6:28AM
UK Regulatory
TIDMTTM TIDMHLO
RNS Number : 2780Y
Ares Capital Europe Ltd
20 February 2013
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the party to the offer making the Ares Capital Europe Limited, Ares Capital Europe
disclosure: (Luxembourg) S.a r.l. and Toscafund Asset
Management LLP
---------------------------------------------------------- ----------------------------------------------------------
(b) Owner or controller of interests and short positions n/a
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient
---------------------------------------------------------- ----------------------------------------------------------
(c) Name of offeror/offeree in relation to whose relevant Healthcare Locums plc
securities this form relates:
Use a separate form for each party to the offer
---------------------------------------------------------- ----------------------------------------------------------
(d) Is the party to the offer making the disclosure the OFFEROR
offeror or the offeree?
---------------------------------------------------------- ----------------------------------------------------------
(e) Date position held: 19 February 2013
---------------------------------------------------------- ----------------------------------------------------------
(f) Has the party previously disclosed, or is it today NO
disclosing, under the Code in respect
of any other party to this offer?
---------------------------------------------------------- ----------------------------------------------------------
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary shares of 10 pence each
-------------------------------------------------- ---------------------------------------------
Interests Short positions
-------------------------------------------------- ------------------------- ------------------
Number % Number %
-------------------------------------------------- ---------------- ------- ------------- ---
(1) Relevant securities owned and/or controlled: 614,531,352* 72.49
-------------------------------------------------- ---------------- ------- ------------- ---
(2) Derivatives (other than options): n/a
-------------------------------------------------- ---------------- ------- ------------- ---
(3) Options and agreements to purchase/sell: n/a
-------------------------------------------------- ---------------- ------- ------------- ---
TOTAL: 614,531,352 72.49
-------------------------------------------------- ---------------- ------- ------------- ---
* These are held as follows:
(a) Ares Capital Europe Limited - 131,625,000 comprising
15.53%
(b) Ares Capital Europe (Luxembourg) S.a r.l. - 125,000,000
comprising 14.74%
(c) Toscafund Asset Management LLP - 357,906,352 comprising
42.22%
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: n/a
---------------------------------------------------------------------------- ----
Details, including nature of the rights concerned and relevant percentages:
---------------------------------------------------------------------------- ----
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(c) Irrevocable commitments and letters of intent
Details of any irrevocable commitments or letters of intent procured by the party to the offer
making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of
the Code):
-----------------------------------------------------------------------------------------------
n/a
-----------------------------------------------------------------------------------------------
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe of
any person acting in concert with the party to the offer making the
disclosure:
---------------------------------------------------------------------------
Concert Party Interests
------------------------ -------------------------------------------------
Nature of Interest Number %
------------------------ ------------------------------- ----------- ---
(A) Persons acting in concert with Ares Capital Europe Limited
---------------------------------------------------------------------------
n/a
------------------------ ------------------------------- ----------- ---
(B) Persons acting in concert with Ares Capital Europe (Luxembourg)
S.a r.l.
---------------------------------------------------------------------------
n/a
------------------------ ------------------------------- ----------- ---
(C) Persons acting in concert with Toscafund Asset Management LLP
---------------------------------------------------------------------------
n/a
------------------------ ------------------------------- ----------- ---
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 3 for each additional class of
relevant security.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the party to the offer making the disclosure or any person acting
in concert with it:
If there are no such agreements, arrangements or understandings, state "none"
------------------------------------------------------------------------------------------------
None
------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the party
to the offer making the disclosure, or any person acting in concert with it, and any other
person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
----------------------------------------------------------------------------------------------
None
----------------------------------------------------------------------------------------------
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
------------------------------------- ---
Supplemental Form 8 (SBL) NO
------------------------------------- ---
(1) Date of disclosure: 19 February 2013
------------------------------------------------------------------------ -----------------
(2) Contact name: David Tyrrell
------------------------------------------------------------------------ -----------------
(3) Telephone number: 020 7665 4500
------------------------------------------------------------------------ -----------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEETMMLTMBBTMLJ
Healthcare Locums (LSE:HLO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Healthcare Locums (LSE:HLO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024